Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Anovulation, Date of authorisation: 27/09/2013, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Anovulation, Date of authorisation: 27/09/2013, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Azilect, rasagiline, Parkinson Disease, Date of authorisation: 21/02/2005, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Azilect, rasagiline, Parkinson Disease, Date of authorisation: 21/02/2005, Revision: 23, Status: Authorised

Contact details of national competent authorities for requests of translation exemptions falling under Art. 63.3 of Directive 2001/83/EC and cases of shortages

Contact details of national competent authorities for requests of translation exemptions falling under Art. 63.3 of Directive 2001/83/EC and cases of shortages

Contact details of national competent authorities for requests to use a sticker to place the Unique Identifier on the outer/immediate packaging of centrally approved products

Contact details of national competent authorities for requests to use a sticker to place the Unique Identifier on the outer/immediate packaging of centrally approved products

Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Multiple Myeloma, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Nexpovio, selinexor, Multiple Myeloma, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness